http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
The State-of-Play of Anomalous Microwave Emission (AME) research
Dickinson, Clive,Ali-Haï,moud, Y.,Barr, A.,Battistelli, E.S.,Bell, A.,Bernstein, L.,Casassus, S.,Cleary, K.,Draine, B.T.,Gé,nova-Santos, R.,Harper, S.E.,Hensley, B.,Hill-Valler, J.,Hoang, Th Elsevier 2018 New astronomy reviews Vol.80 No.-
<P><B>Abstract</B></P> <P>Anomalous Microwave Emission (AME) is a component of diffuse Galactic radiation observed at frequencies in the range ≈ 10–60 GHz. AME was first detected in 1996 and recognised as an additional component of emission in 1997. Since then, AME has been observed by a range of experiments and in a variety of environments. AME is spatially correlated with far-IR thermal dust emission but cannot be explained by synchrotron or free–free emission mechanisms, and is far in excess of the emission contributed by thermal dust emission with the power-law opacity consistent with the observed emission at sub-mm wavelengths. Polarization observations have shown that AME is very weakly polarized ( ≲ 1 %). The most natural explanation for AME is rotational emission from ultra-small dust grains (“spinning dust”), first postulated in 1957. Magnetic dipole radiation from thermal fluctuations in the magnetization of magnetic grain materials may also be contributing to the AME, particularly at higher frequencies ( ≳ 50 GHz). AME is also an important foreground for Cosmic Microwave Background analyses. This paper presents a review and the current state-of-play in AME research, which was discussed in an AME workshop held at ESTEC, The Netherlands, June 2016.</P>
The [C ii] emission as a molecular gas mass tracer in galaxies at low and high redshifts
Zanella, A,Daddi, E,Magdis, G,Diaz Santos, T,Cormier, D,Liu, D,Cibinel, A,Gobat, R,Dickinson, M,Sargent, M,Popping, G,Madden, S C,Bethermin, M,Hughes, T M,Valentino, F,Rujopakarn, W,Pannella, M,Bourna Oxford University Press 2018 MONTHLY NOTICES- ROYAL ASTRONOMICAL SOCIETY Vol.481 No.2
Altaf Mohammed,Roderick H. Dashwood,Sally Dickinson,Mary L. Disis,Elizabeth M. Jaffee,Bryon D. Johnson,Samir N. Khleif,Michael N. Pollak,Jeffrey Schlom,Robert H. Shoemaker,Sasha E. Stanton,Georg T. Wo 대한암예방학회 2021 Journal of cancer prevention Vol.26 No.4
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.